As per our research analysis, the Middle East and African Diabetes Devices Market has been estimated at USD 1.45 billion in 2022 and is projected to reach USD 1.97 billion by 2027, at a CAGR of 6.34% during the forecast period. Diabetes is a group of metabolic disorders, chronic condition which is associated with an abnormally high level of sugar (glucose) in the blood. The Middle East and North Africa currently witness 35.4million people affected with Diabetes, which is going to reach 72.1 million by 2040. The rest of the Africa region witnesses 14.2 million people affected with diabetes, and this number is said to reach 34.2 million by 2040.
In the Middle East & Africa, the market is majorly driven by the rising awareness about disease care. With the increasing incidence of chronic diseases, there is an increase in demand leading to market growth. But the market here is mainly constrained due to low medical literacy. Health literacy influences essential health outcomes, including the acquisition of new disease-specific knowledge, improving self-efficacy, and adherence to self-care behaviors. Low health literacy has been consistently associated with worse diabetes knowledge in a variety of settings, including ambulatory and hospitalized patients.
Diabetes management modules will help in improving health literacy by enabling them to understand various diagnostics and devices. Therefore, health literacy improvement will help the emerging market like MEA to poise a good future in Diabetes Care Devices Market. Increasing the costs of medical devices is another constraint that’s restricting sales in this region. The high price of the devices is due to the technology involved in them. In most of the African countries, the reach of medical devices itself is challenging. On top of that, the high price of the devices is a tremendous burden for the customers, thus, restricting the sales of the devices in this region.
Noteworthy companies operating in the MEA Diabetes Care Devices Market are Roche Diagnostics, Johnson & Johnson, Abbott Laboratories, Novo Nordisk, Ascensia, Tandem, and Terumo.
This research report segmented and sub-segmented into the following categories:
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org